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Cancer incidence in England and Wales and New Zealand and in migrants
between the two countries
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Say Risks of cancer incie in people born in Fgland and Wales and New Zealand (non-Maoris)
living in their home countie and after migration between the two countris, were analysed using data from
their national cancer registries. Since these populos are of simila genetic origin, any real in
cancer incidence between thm are likely to reflect the action ofenvironmental or behavioural risk factors. The
greatest diffees in risk between the countries were for cutaneous lan a and p cancer. In each sex,
relative risks of these malignances wer 4 or greater for the New Zealand-bor m New Zealand
with Englih and Welsh natves in their home country, and risks for migrants each direction wer generally
intermeiate between-those born in the home country in the two countries. Sizab significantly raised risks in
the New Zealand-born in New Zealand compared with and Welsh natives i England and Wales also
occurred for cancers of the mouth, small intestie, colon, thymus, eye and thyroid, and non-Hodgkin's
lymphoma m each sex, and for cancer of the prostate. For all of these sites except mouth, small mtestn and
colon there were also risks around or above New Zealand-bom levels for Engiish and Welsh migrants to New
aland- for colon cancer these migrants had risks dlose to those in Fngland and Wales. New Zealnd
migrants to England and Wales had risks of cancers of the colon and prostate that we similar to or above
New Zealand levels. Risks of canrs of the stomach, pleura and bladder, and Hodgkin's sea each
sx, and cancrs of the cervix, ovary and scrotm and penis, were substantially and significantly lower in the
New Zland-born hving in New Zealand than m English and Welsh natives in England and Waks. In Engish
and Welsh migrants to New Zealand risks of bldder cancer m each sex, and of scrotal and penile and pleural
camcer in mals, approximated to England and Waks risks; cevical cancr risk approximated to the New
Zealand risk; and stomach, hmg and ovarian cancers showed intermediate risks. Migrants from New Zealand
to England and Wales did not gain the hmg cancer or dearly the stomach cancer risk of their host country,
but did have bladder cancer risks approxmating to those m England and Wals. The results suggt that
exposure to the New Zealand environment or behaviours early or late in life can lead to raised risks of
melanoma, lip cancer and prostatic cance, that migration to New Zaland may lead to some extent to the
acquistion of raised risk of cancer of the eye and posiUbly of caurs of the thymus, thyroid and non-
Hodgkin's lymphoma; and that exposures or behaviours early in life are critical to the high risks of colon
cancer in persons born in New Zealand Exposures early in life in England and Wales appear able to lead to
raised risk of lung cancer and probably also of cncers of the plura and scrotum and penis, and exposures
early or late in life in England and Wales may rane the risk of bladder cancer.
Keywori cancer incidence; migrants
Migrant studies have played an important part in demon-
strating the environmental origins of many cancers, by show-
ing sizeable changes in risk with residence in the new country
(Haenszel, 1982). Migrant groups, however, are often very
different genetically from the native population of the
country to which they migrate, and therefore it is difficult to
know whether residual differences in cancer risk between the
immigrants and the natives of the host country are genetic or
are due to differences in behaviour or early environment.
Risks in migrants can give information on the likely age at
which caranogens act, since the early exposures of the mig-
rants will be in their native country and the later exposures
in the host country. Comparative data on migrants in both
directions between two countries ought to be particularly
informative, since factors actng early in life should increase
risk in migrants from the high- to low-risk country but not in
migrants in the opposite direction, while factors acting late
should have the reverse effect. To our knowledge, however,
there have been no such studies in two-way migration.
The first Europeans known to have reached New Zealand
were Tasman, a Dutchman, and his crew in 1642, but the
great majority of early colonists were British. Subsequent
migration from Britain to New Zealand has been of such an
extent that, unusually, the New Zealand non-aboriginal (non-
Maori) population is largely of British descent (McLintockc,
1966). There has also been appreciable migration in the
opposite direction. The preset study uses data from the
national cancer registries of England and Wales and New
Zealand to assess comparative cancer risks in residents born
in the two countries and migrants between them.
Material and nhom
Cancer registration in England and Wales has been con-
ducted on a national basis since 1945, with complete geo-
graphic coverage of the country sine 1962 (Swerdlow, 1986).
Country of birth has been recorded in the national cancer
registration files since 1971. The data presented here relate to
the years ofincidence for which registrations were reasonably
complete at the time that data were extracted for this study:
1971-83.
In New Zealand, cancer registration has been conducted
nationally since 1948, and became population based in 1972
(Fmdlay et al., 1987). The data analysed in this study are for
1972-84. During this period people were generally defined as
Maori if they reported half or more Maori ancestry, and the
term non-Maori covered all other persons. While the non-
Maori population will have included people with some Maori
ancestry, the overall effect of this would not have been great
because the Maori population accounted for less than 10%
of the total population.
Country of birth was recorded for 95% of registrations in
New Zealand, but in the England and Wales data this
variable was known for only 69% of cases. Calculation of
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incidnc rates could therefore be seriously biased, and we
analysed the data instead by means of age-adjusted odds
ratios (Mantel and Haenszel, 1959). These should be
unaffected by incompletness provided that it is of about the
same degree for different cancer sites. The odds ratios com-
pared the risk of each cancer in each migrant group, and in
New Zealand-born people (whom we will refer to as New
Zealanders) in NZ, with the risk in the Engad and Wales-
born (whom we will refer to as English and Welsh) in
England and Waks, the lagest group in the study, as the
baseline. The cases in these analyses were the cancer of
interest (i.e. successively each cancer site) and the controls
were based on all cancers except the cas malignancy and
non-melanoma skin caer. The latter was excluded entirely
from the analyses because it was not registered in New
Zealand.
Two different methods were used to obtain the controls
from among the non-case cancers. The results using these
methods were then compared to help to assess whether con-
trol selection might have biased the reults. Firsty, analyses
were conducted using all registrations except those with the
case malignancy as the controls; we have referred to these as
the unweighted analyses. Secondly, analyses were conducted
in which a weighted sample of all non-case egistrations was
used as the controls. The weighting was such that in each 5
year age group, no three-digit ICD cancer site constituted
more than 5% of the controls. This was done to avoid the
domination of the controls by a few common sites, such as
lung cancer, whose risk would otherwise tend to affect recip-
rocally the apparent risk of all other tumours, sice in each
population the total of all cancers must be 100%. Details of
the method of weighting can be found in Swerdlow and dos
Santos Silva (1991).
Site of ancer was coded in the England and Wales files to
ICD8 (WHO, 1967) for caurs icident in 1971-78 and to
ICD9 (WHO, 1977) for 1979-83. Bridge cding was con-
ducted, using fourth digit ICD8 data as required, to give the
ICD9 categories shown in Tabes II and m for the entire
period. The New Zealand data were coded to ICD8 for
1972-79 and ICD9 for 1980-84, and again bridge coding
was conducted to give the same ICD9 categories throughout.
The coding of New Zalanders and English and Welsh in
the New Zealand data was staightforward, as was the
coding of New Zealanders in the England and Wales data.
Identification of Englsh and Welsh in England and Wales
was less simple, however, because of the several ways, vary-
ing specifity, which people born in the British Isles can
have their birth place recorded in the canr files. Egish
and Welsh natives were taken to be those whose birth place
was stated as England and Wales, or as Britain or United
Kingdom not specified. The last two categones were inclued
becuse they constitute about one-third of all registtions in
Engand and Wales and are likely to be largely England and
Wales-born.
To gain demographic description of the New Zealand mig-
rants to England and Wales, for interpretation of the cancr
risks, we used unpublished data and specially run tabulations
from the 1971 census. At this census more detailed questions
than usual were asked about migrants and about female
emproductive history. We also obtained comparable New Zea-
land data, as far as possible, from the 1976 census, usng
published data (Department of Stastics, 1980) and an
unpublished table previously described (Cooke and Fraser,
1985).
Resnls
The native-born population of England and Wales in 1971
was 44563 700, and the New Zealand-born non-Maori
population of New Zealand in 1976 was 2339514. The
England and Wales-born population ofNew Zealand in 1976
was 228 175, and the New Zealand-born population of Eng-
land and Wales in 1971 was 19680. Migration of New
Zealanders to England and Wales has ocured fairly sadly
over many years, being a mixture of long-term migrants and
short-term students and other temporary immigrants: at the
1971 census, 20% of New Zealanders in England and Wales
had arrived before 1940, 19% during 1940-59, 38% during
1960-69 and 24% during 1970-71. For the great majority of
the immigrants, both parents were born in Britain (27.5%),
or both parents were born in the 'Old Commonwealth'
(44.0%) (the census coding category for NZ, Australia and
Canada, and therefore likely to be largely New Zealanders in
this n e), or one parent was born in each (21.3%). New
ealand immigrants were on average of higher social class
(based on own occupation, and excluding persons of un-
clasified or unknown class) than English and Welsh natives
in and and Wales: 59% of New Zeland-born men and
41% of New Zealand-born wormen were in classes I and H
compared with 24% of men and 17% of women among
English and Welsh natives. Tbirty-three per cent of New
Zealand female immigrants aged 40-59 were single (15.9%)
or married but nulliparous (17.2%), and the mean parity of
these migrants was 1.63, compared with 20.7% who were
either single (8.1%) or married nulliparous (12.6%), and a
mean parity of 1.89, among England and Wales native
women of the same age. Parity was only recorded at the
census for chikld born within marriage. We have therefore
had to assume for the calculation of parity that all single
women were nulliparous.
Migration from England and Wales to New Zeland has
occurred over many d s but the number of migrants
increased after the Second World War: at the 1976 New
Zeland census, 18% of English and Welsh in New Zealand
had arrived before 1947, 29% during 1947-61, 26% during
1962-71 and 28% during 1972-76, when there was a short-
lived but lawrg increase in the inflow of British immigrants.
Immigrants from England and Wales had higher fertility
rates (live births per 1000 women aged 15-44 years) than
women in England and Wales and lower rates than New
Zealand-born non-Maori women. Much of the difference
between New Zealand-born non-Maori women and English
and Welsh-born women in New Zealand, however, is
attributable to age differences, as age-standardised fertlity
ratios were similar for the two groups (Ferns, 1974). Data
are not available on the social class composition ofmigrants
to New Zealand during the relevant period.
The numbers of cncers on which the analyses of cancer
risk were based are shown in Table I. There were large
numbers for the native populations of New Zealand and
England and Wales in their home countries, and for the
England and Wales-born in New Zealand, but far fewer for
New Zealanders in Englnd and Wales, with consequent
lower precision of the cancr risk estimates for this group.
Tables II and HI show risks of cancer in the migrant
groups, and in New Zealanders in New Zeland, compared
with English and Welsh in England and Wales. The data
presented are from the 'unweighted' analyses (see Materials
and methods). Wlhere the 'weighted' analyses gave substan-
tially different results from these, they are quoted in the text.
Lip, oral andpharyngeal cacers
Risks oflip cancer were 4- to 5-fold sin tly icased in
each sex in New Zealanders in New Zealand, compared with
English and Welsh in England and Waks. Risks for EngLish
and Welsh migrants to New Zealand were intmediate
Tie I Numbers ofcancersincident in English and Welsh and New
Zaandersin Eland Wales 1971-83 andN 1972-84,
by country ofbirth and country ofresidenc
Nwnber ofcancers incident
Maks Femoals
NewZcala iersn NZ 41 488 42 390
English and Welsh in NZ 7060 6072
New Zelanders i England and Wales 193 236
English and Welsh in England and Waks 759495 701 302
237
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Table H Risks of cancer in England and Wales and New Zealand and in migrants between the two countries: males (unweighted)
Cancersite E& WinE& W NZinE& W E&WinNZ NZinNZ
(ICD9) No. OR No. OR (95% CI) No. OR (95% CI) No. OR (95% CI)
Lip (140)
Salivary glands (142)
Other oral (141, 143-145)
Nasopharynx (147)
Other pharynx (146, 148-149)
Cesophagus (150)
Stomach (151)
Small intestine (152)
Colon (153)
Rectum (154)
Liver (155)
Gal bladder (156)
Pancreas (157)
Nose (160)
Larynx (161)
Lung (162)
Pleura (163)
Thymus (164.0)
Bone (170)
Soft tissue (171)
Melanoma (172)
Breast (175)
Prostate (185)
Testis (186)
Other male genital (187)
Bladder (188)
Kidney (189)
Eye (190)
Brain and other nervous system
(191-192)
Thyroid (193)
il-defined (195-199)
Hodgkin's disease (201)
Non-Hodgkin's lymphoma
(200, 202)
Multiple myeloma (203)
Leukaemia (204-208)
2062 1.00 1 1.93 (0.27-13.77)
1584 1.00 1 1.83 (0.26-13.07)
5856 1.00 2 1.31 (0.33-5.29)
843 1.00 0
4112 1.00 1 0.96 (0.14-6.89)
18 950 1.00 7 1.58 (0.74-3.36)
69 847 1.00 14 0.86 (0.50-1.48)
1461 1.00 1 2.65 (0.37-18.94)
52 093 1.00 22 1.84 (1.18-2.88)**
42 442 1.00 17 1.75 (1.06-2.88)*
4584 1.00 0
4327 1.00 1 0.97 (0.14-6.95)
28 084 1.00 7 1.06 (0.50-2.25)
1908 1.00 0 -
10 592 1.00 3 1.15 (0.37-3.61)
260 935 1.00 34 0.46 (0.31-0.67)***
2238
158
1935
3203
4309
1.00
1.00
1.00
1.00
1.00
0
0
1
1
4
0.86 (0.11-6.93)
0.77 (0.11-5.49)
2.44 (0.88-6.78)
1369 1.00 0
64083 1.00 21 1.62 (1.01-2.59)*
5795 1.00 5 1.14 (0.42-3.08)
2371 1.00 0 -
48 730 1.00 14 1.23 (0.71-2.12)
13 924 1.00 4 1.07 (0.40-2.89)
1357 1.00 0
12 973 1.00 9
1536 1.00 0
36 254 1.00 7
1.74 (0.87-3.47)
0.78 (0.37-1.66)
6387 1.00 5 1.36 (0.51-3.60)
13 146 1.00 4 0.90 (0.33-2.45)
7617 1.00 2 1.10 (0.27-4.42)
19 350 1.00 2 0.29 (0.07-1.12)
25 1.27 (0.85-1.88)
11 0.74 (0.41-1.34)
45 0.81 (0.61-1.09)
5 0.68 (0.28-1.64)
44 1.15 (0.85-1.55)
130 0.73 (0.61-0.86)***
567 0.85 (0.78-0.93)***
20 1.49 (0.96-2.32)
572 1.16 (1.07-1.27)***
385 0.96 (0.86-1.06)
63 1.51 (1.17-1.93)**
46 1.13 (0.84-1.51)
226 0.85 (0.75-0.97)*
17 0.96 (0.60-1.55)
97 1.01 (0.82-1.23)
1843 0.69 (0.65-0.72)***
21
4
22
41
158
1.04 (0.68-1.60)
2.89 (1.07-7.80)*
1.50 (0.98-2.30)
1.47 (1.08-2.00)*
4.08 (3.46-4.80)***
13 1.01 (0.58-1.74)
1009 1.71 (1.60-1.83)***
68 1.30 (1.00-1.69)
28 1.24 (0.85-1.80)
523 1.15 (1.05-1.26)**
184 1.48 (1.28-1.72)***
18 1.62 (1.02-2.58)*
147 1.41 (1.19-1.66)***
28 1.96 (1.35-2.86)***
182 0.52 (0.45-0.60)***
39 0.71 (0.51-0.97)*
150 1.28 (1.09-1.51)**
106 1.50 (1.23-1.82)***
199 1.21 (1.05-1.39)*
*P<0.05;**P<0.1;***P<0.001. OR, age-adjusted odds ratio; Cl, confidence interval.
463 4.04 (3.64-4.48)***
177 1.69 (1.45-1.98)***
486 1.48 (1.35-1.62)***
53 0.98 (0.74-1.29)
292 1.30 (1.15-1.46)***
832 0.82 (0.77-0.88)***
2191 0.58 (0.55-0.60)***
149 1.79 (1.51-2.13)***
4373 1.63 (1.58-1.68)***
2806 1.26 (1.21-1.31)***
340 1.37 (1.22-1.53)***
257 1.12 (0.99-1.27)
1307 0.87 (0.83-0.93)***
104 0.94 (0.77-1.15)
629 1.08 (1.00-1.17)
8518 0.51 (0.50-0.52)***
55
39
155
323
2276
0.42 (0.32-0.55)***
2.99 (2.10-4.26)***
1.04 (0.88-1.23)
1.47 (1.30-1.65)***
7.59 (7.19-8.01)***
80 1.05 (0.84-1.32)
5421 1.93 (1.87-1.99)***
833 1.18 (1.09-1.28)***
90 0.67 (0.54-0.82)***
1852 0.71 (0.67-0.74)***
1065 1.37 (1.29-1.46)***
146 1.87 (1.57-2.22)***
935 1.07 (1.00-1.14)
171 1.66 (1.42-1.95)***
1544 0.78 (0.74-0.83)***
429 0.68 (0.61-0.75)***
1131 1.37 (1.29-1.45)***
560 1.37 (1.26-1.50)***
1220 1.12 (1.06-1.19)***
between those for natives in the two countries. Risks for New
Zealanders in England and Wales were high, but based on
only one case in each sex.
Risks of salivary gland cancer and of other oral cancers
were greater in New Zealanders in NZ than in English and
Welsh in England and Wales, while English and Welsh mig-
rants to NZ had risks somewhat below those in their native
country. Nasopharyngeal cancer risks showed no pattern or
significant findings (except for a marginally significant
decrease in female New Zealanders in NZ in the weighted
analysis). Risks of other pharyngeal cancers in New
Zealanders in NZ were significantly increased in males, in the
unweighted but not the weighted analysis, and significantly
decreased in females in both analyses, compared with the
risks in English and Welsh natives in England and Wales.
Risks in English and Welsh migrants to NZ were inter-
mediate between those in their native and adopted countries
(except in the weighted analyses for males, where relative
risks were close to unity for New Zealanders and English and
Welsh in NZ).
Digestive organ cancers
Risks of oesophageal cancer in each sex were significantly
and similarly decreased in New Zealanders and English and
Welsh in NZ, but non-signifiantly increased in New
Zealanders in England and Wales, compared with English
and Welsh in their native country. Stomach cancer risks in
New Zealanders in NZ were just over half those in English
and Welsh natives in their home country, with intermediate
risks occurring in migrants in each direction, except that
female New Zealanders in England and Wales had a risk
close to that in NZ.
Risks of cancer of the small intestine were significantly
raised in New Zealanders in NZ compared with English and
Welsh in England and Wales, but inconsistent and not
significantly raised in the migrants.
In each sex colon cancer risks were over 50% greater in
New Zealanders living in NZ and also living in England and
Wales than in English and Welsh in England and Wales.
Risks in English and Welsh living in NZ, however, were only
slightly greater than when living in England and Wales (or in
the weighted analysis very close to unity). Rectal cancer
relative risks were less markedly raised in New Zealanders in
their home country (and close to unity in the weighted
analysis), and showed no consistent pattern in the migrants.
Liver cancer risks were significantly raised in male New
Zealanders and English and Welsh in NZ compared with
English and Welsh in England and Wales in the unweighted
analysis, but non-significantly raised in the weighted analysis.
In females the relative risk for New Zealanders in NZ was
less markedly raised than in males (and significant only in the
unweighted analysis), and for English and Welsh in NZ was
non-significantly decreased.Cancer i E,aud, ed NZ
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Table m Risks of cancer in England and Wales and New Zealand and in migrants between the two countries: females (unweighted)
Cancer site E& WinE& W NZ in E & W E& Win NZ NZ in NZ
(ICD9) No. OR No. OR (95% CI) No. OR (95% CI) No. OR (95% CI)
Lip (140)
Salivary (142)
Other oral (141, 143-145)
Nasopharynx (147)
Other pharynx (146, 148-149)
Oseophagus (150)
Stomach (151)
Small intestine (152)
Colon (153)
Rectum (154)
Liver (155)
Gall bladder (156)
Pancreas (157)
Nose (160)
Larynx (161)
Lung (162)
Pleura (163)
Thymus (164.0)
Bone (170)
Soft tissue (171)
Melanoma (172)
Breast (174)
Uterus unspecified (179)
Cervix (180)
Placenta (181)
Body of uterus (182)
Ovary (183)
Other female genital (184)
Bladder (188)
Kidney (189)
Eye (190)
Brain and other nervous system
(191 -192)
Thyroid (193)
ill-defined (195-199)
Hodgkin's disease (201)
Non-Hodgkin's lymphoma
(200, 202)
Multiple myeloma (203)
Leukaemia (204-208)
408 1.00 1 8.14 (1.14-58.26)*
1593 1.00 0 -
3898 1.00 1
509 1.00 0
2485 1.00 0
15 283 1.00 7
0.80 (0.11 -5.71)
1.59 (0.75-3.39)
49 565 1.00 6 0.40 (0.17-0.90)*
1397 1.00 1 2.20 (0.31-15.72)
71 384 1.00 37 1.90 (1.33-2.72)***
36413 1.00 7 0.63 (0.30-1.33)
3487 1.00 0 -
7027 1.00 0 _
26 137 1.00 8 1.03 (0.51-2.10)
1500 1.00 0 -
2265 1.00 0 -
72244 1.00 16 0.67 (0.40-1.11)
714 1.00 0 -
133 1.00 0 -
1553 1.00 0
3543 1.00 3 2.11 (0.67-6.68)
8330 1.00 14 3.96 (2.25-6.98)***
167029 1.00 63 1.09 (0.81-1.47)
3564 1.00 1 0.85 (0.12-6.06)
31 684 1.00 8 0.53 (0.26-1.08)
116 1.00 0 -
27543 1.00 10 1.11 (0.59-2.09)
38 556 1.00 13 0.95 (0.54-1.66)
8716 1.00 2 0.74 (0.18-2.97)
18 707 1.00 7 1.25 (0.59-2.67)
8768 1.00 4 1.41 (0.52-3.78)
1396 1.00 1 2.11 (0.30-15.08)
9546 1.00 8 2.04 (1.00-4.17)
4380
27 147
4164
11 898
1.00
1.00
1.00
1.00
0
0.59 (0.24-1.44)
0.40 (0.06-2.82)
0.23 (0.03-1.65)
7847 1.00 3 1.26 (0.40-3.96)
16 288 1.00 6 1.09 (0.47-2.51)
7 1.96 (0.93-4.14)
9 0.65 (0.34-1.24)
26 0.77 (0.52-1.13)
5 1.19 (0.49-2.86)
16 0.75 (0.46-1.23)
87 0.64 (0.52-0.79)**
305 0.68 (0.60-0.76)***
8 0.66 (0.33- 1.33)
680 1.10 (1.01 -1.19)*
315 0.99 (0.88-1.11)
24 0.80 (0.53-1.19)
70 1.15 (0.91-1.46)
181 0.79 (0.68-0.91)**
13 1.00 (0.58-1.73)
14 0.72 (0.43-1.22)
502 0.80 (0.73-0.87)***
3 0.50 (0.16-1.54)
6 5.46 (2.41-12.39)***
4 0.35 (0.13-0.93)*
48 1.71 (1.28-2.28)***
214 3.08 (2.67-3.54)***
1562 1.10 (1.03-1.16)*
11 0.35 (0.20-0.64)**
210 0.74 (0.64-0.85)*
1 1.00 (0.14-7.16)
278 1.19 (1.06-1.35)*
282 0.84 (0.75-0.95)*
70 0.92 (0.72-1.16)
158 0.97 (0.83-1.14)
71 0.96 (0.76-1.22)
21 1.98 (1.29-3.06)*
87 1.26 (0.94- 1.44)
49
292
45
150
1.29 (0.97-1.71)
1.25 (1.11-1.40)***
1.31 (0.97-1.76)
1.49 (1.27- 1.76)***
79 1.17 (0.93- 1.46)
139 1.06 (0.90-1.26)
106 4.86 (3.93-6.04)***
126 1.10 (0.91-1.32)
327 1.49 (1.33-1.67)***
23 0.68 (0.45-1.03)
76 0.52 (0.41 -0.65)***
489 0.61 (0.56-0.67)***
1413 0.54 (0.51-0.57)***
121 1.48 (1.23-1.78)***
5689 1.58 (1.53-1.62)***
2301 1.19 (1.14-1.24)***
229 1.19 (1.04-1.36)*
410 1.12 (1.01 -1.24)*
1014 0.73 (0.69-0.78)***
53 0.61 (0.46-0.80)***
79 0.57 (0.45-0.71)***
2712 0.62 (0.60-0.64)***
12 0.27 (0.15-0.48)***
22 1.97 (1.25-3.08)**
141 1.26 (1.05-1.50)*
248 1.00 (0.88-1.14)
3211 5.31 (5.09-5.55)***
10 165 0.90 (0.88-0.92)***
58 0.27 (0.21 -0.35)***
2021 0.79 (0.76-0.83)***
27 1.47 (0.96-2.24)
1945 1.17 (1.12-1.23)***
1902 0.74 (0.71-0.78)***
410 0.86 (0.78-0.95)**
629 0.62 (0.58-0.68)***
577 1.15 (1.06-1.25)**
110 1.34 (1.10-1.63)**
662 0.96 (0.89-1.05)
469 1.48 (1.34-1.63)***
1736 1.18 (1.13-1.25)***
305 0.74 (0.66-0.83)***
957 1.30 (1.22-1.39)***
499 1.19 (1.09-1.31)***
963 1.05 (0.98-1.12)
*P<0.05; **P<0.01; ***P<0.O00. OR, age-adjusted odds ratio; CI, confidence interval.
Gall bladder cancer relative risks in each sex were slightly
above unity for New Zealanders and English and Welsh in
NZ in the unweighted data, but close to or below unity in
the weighted analysis.
Risks of pancreatic cancer in each sex were significantly
but not greatly decreased in New Zealanders and English and
Welsh in NZ, but, based on small numbers, risks for New
Zealanders in England and Wales were similar to those of
English and Welsh in England and Wales.
Cancers ofrespiratory and intrathoracic organs
Nasal cancer nsks in New Zealanders in NZ were sig-
nificantly below unity for females in the unweighted analysis
and for both sexes in the weighted analysis, but otherwise
risks were non-significant, based on small numbers. In males
laryngeal cancer risks for New Zealanders and English and
Welsh in NZ were close to unity in the unweighted analysis
and moderately below unity in the weighted analysis. In
females these risks were substantially below unity, although
significantly so only in the New Zealanders.
Lung cancer risk in New Zealanders in NZ were well
below the risks for English and Welsh in England and Wales,
and risks were similarly reduced in New Zealanders in Eng-
land and Wales. Risks for English and Welsh in NZ were
intermediate between these levels. Risks of pleural cancer
were significantly lower in New Zealanders in NZ than in
English and Welsh in England and Wales. Based on small
numbers, English and Welsh migrants to NZ had risks close
to those in England and Wales in males and intrmediate in
females.
Thymus cancer risks were substantially higher in both New
Zealanders and English and Welsh in NZ than in English
and Welsh in England and Wales. These raised risks were
significant in the unweighted analysis, and were significant in
all instances except male English and Welsh in NZ in the
weighted analysis.
Bone, soft-tissue and skin cancers
Bone cancer risks showed no consistent pattern. Soft-tissue
cancer risks were significantly raised in male but not female
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New Zealanders m NZ, and in both sexes of English and
Welsh in NZ (except not for males when weighted), com-
pared with English and Welsh in England and Wales.
Melanoma risks in New Zealanders in NZ were several-
fold those in English and Welsh in their home country. Risks
in migts m each dirction were intermedte, and were
significantly raised except for male New Zealanders in Eng-
land and Wales.
Breast andfemale reproductive organ cancers
In femals, risk of breast cancer in New Zealanders in NZ
was slightly lower than in English and Welsh in England and
Waks, but risks in migrants in each direction were slightly
increased. Breast cancer relative risks in males did not differ
signiicantly from unity.
Risk of cervical cancer in New Zealanders in NZ and in
both migrant groups was low compared with that in English
and Welsh in England and Waks, significantly so except in
New Zealanders in England and Wales. Risk ofcancer ofthe
body of uterus was slightly greater in New Zealanders in NZ
and in both migrant groups than in Englsh and Welsh living
in England and Wales. Uterine cancers not specified whether
of cervix or corpus were a alle component of New Zea-
land registry data than of Englnd and Waks data, but in
migrants and natives in each country were under 6% of all
uterine cancers, and hence could not have had a sizeable
effect on the site-specific uterine cancer comparisons between
the study groups.
Ovarian cancer risk was signifiantly reduced in New
Zealanders and to a ksser extent Englsh and Welsh in NZ
compared with English and Welsh in England and Wales.
New Zealand migants to England and Waks had a risk
close to that of English and Welsh natives, but based on
small numbes Risk of other femak genital cacers was
significantly but not greatly lower in New Zealanders in NZ,
and slightly lower in sh and Welsh migrants in NZ,
than in E and Welsh in Engand and Wales
Male reproductive organ cancers
Prostatic cancer risk was almost twice as great in New
Zealanders in NZ as in English and Welsh in England and
Wales. EngLish and Welsh migrants to NZ had ahnost the
native NZ risk, and NZ migrants to England and Wales also
had a significantly increased risk. The risks in the New
Zealand-born and migrants in NZ were less raised but still
highly sigifct in the weighted analysis (RRs of 1.36 and
1.37 re ly). Tescular cancer risk was moderately in-
creased in New Zealanders in NZ, and in migrants in each
direction, compared with English and Welsh in their home
country.
Riskc of other male genital cancers (i.e. largely scrotal and
penile cancers) was siifcantly deeasd in New Zealanders
in NZ, but not decreased in Engsh and Welsh migrants to
NZ, compared with English and Welsh in England and
Wales.
Urinay tract cancers
In each sex bladder cancer risk was nificantly dremed
and renal cancer risk significantly increased (except non-
significantly increased for renal canr in males in the weigh-
ted sanalys) in New Zealanders in NZ comarued with Eng-
ish and Welsh in England and Wales. Bladder cancer risks
were at or above English and Welsh klvs in migrants in
each direction. Risks of renal cancer showed no conistent
patten in the migrants.
Nervous system andendocrine cancers
Eye cancer risks were substantially and nificantly raised in
both New Zelanders and English and Welsh in NZ (except
in the weighted analysis raised but not signint for male
English and Welsh) compared with English and Welsh in
England and Wales. Brain and other nervous system cancer
risks were similar in New Zealanders and English and Welsh
in their home countries, but somewhat raised in migrants in
each direction.
Risks of thyroid cancer were significantly greater in New
Zealanders in NZ than English and Welsh in England and
Wales. English and Welsh in NZ had appreciably raised
risks, signnt in males.
Malignancies oflymphatic andhaematopoietic tissues
Hodgkin's disease risks were significntly decreased and non-
Hodgkin's lymphoma (NHL) risks significantly increased in
New Zealanders in NZ compared with English and Welsh in
Englaind and Wales. Risks in English and Welsh in NZ were
fairly close to those for New Zealanders there, except that
Hodgkin's diseas risk was raised in fenales. Few lym-
phomas ocurred in New Zealanders in England and Wales,
and the risks in this group were not sigificntly different
from unity.
In each sex multiple myeloma risks were moderately raised
in New Zealanders in NZ and each migrant group
(significnt in the unweighted analysis for New Zealanders of
each sex in NZ and male English and Welsh in NZ) com-
pared with English and Welsh in England and Wales.
Leukaemia relative risks were close to unity in females in
all categories. In maes, risks for New Zealanders and Eng-
lish and Welsh living in NZ were significantly increased
compared with those for English and Welsh living in Eng-
land and Wales in the unweighted analysis, but not raised in
the weighted data.
Non-Maori New Zealanders and English and Welsh are
more simila genetically than is usual in populations of diffe-
rent countries. The main difference is a higher proportion of
people of Scottish or Irish descent in New Zealand (McLin-
tock, 1966). Medical diagnostic methods and terminology are
also very similar in these countries - many New Zealand
doctors have trained or worked in Britain. Neverthekss,
there are potential artefacts which might occur in comparing
cancer regisation data between these countries, and which
need consideration.
Cancer registration in England and Wales in 1971-83 was
about 90% complete (Swerdlow et al., 1993) and in New
Zealand in 1972-84 was reported to be at least 95% com-
plete (Findlay, 1989). There was also a difference between
these registris in the proportion of registrations for which
country ofbirth was known: 69% in England and Wales and
95% in New Zealand. These differences would bias a com-
parison of ancer incidnc rates between the two countries
(since incompkteness would lead to reduced rates). They
should not, however, affect the odds ratios used in the pres-
ent analyses (since incompleteness should affect the exposure
status of the cases and controls similarly), unkss the propor-
tion of incident canrs that were not registered with a
known country of birth varied by cancer site or age in ways
appreciably different between the countries or nativity
groups. Odds ratios, however, are susceptible to bias if the
controls (i.e. all cancers except the site under study) are not
representative of the catchment population. This will depend
particularly on the distribution between NZ, England and
Wal, and the migrant groups of the commonest tumours -
for instanc the high lung caer risk in English and Welsh
in England and Waks will tend to have a reciprocal effect of
artefactually reducing apparent risks for all other sites in that
population group, since in each group the total ofall canrs
must be 100%. To gain some ition of where such bias
might be occurring, we conducted analyses also usng a
'weighted' control set, where the contribution of the com-
monest tumours was no greater than that of less common
maii. Results that were robust to whether weightedCm in E, s Wdu NZ
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or unweighted analyses were conducted are less likely to be
artefactual. A second check on potential bias for the two
non-migrant groups in the study is to examine published
registration rates for NZ (non-Maoris) and England and
Wales (Muir et al., 1987), as these will largely be formed by
the non-migrants. The all-ages all-cancer rate was slightly
greater for NZ than for England and Wales, which with the
slightly lower registration complteness for England and
Wales compared with NZ implies that incdence rates in the
two countries are probably very similar, and reiprocty bias
probably slght. At young ages, however, all-cancer registra-
tion rates are considrably greater in NZ than in England
and Waks, and therefore the odds ratios for New Zealanders
in NZ may be too low for the few tumours (such as tesicular
cancer and Hodgkin's disease) which occur mainy at
younger ages. In generaL the odds ratios for these caners are
significanty raisd, so that the bias would simply lead to an
underestimate of the magnitude rather than a mistake in the
direction of the cancer risks. Specifically for Hodgkin's
diseas, however, the odds ratios for New Zealanders in NZ
were reduced, and therefore for this tumour the direction of
the nsk may also have been estimated unreliably by the
method.
Migrant data might be biased if appreciabe numbers of
cancer patients travelled from one country to the other for
treatment, and were then mistakenly coded as residents at
cancer registration. Such travel is negigible (if not non-
existent) between England and Wales and New Zealand.
Differences between the study groups in the proportion of
registered canes for which the primary site was unknown
would affect site-specific cancer odds ratios. The proportion
of cancers with site unknown was small in each data set
however (4.3% in English and Welsh in England and Wales,
2.8% in New Zelanders in England and Waks, 3.6% in
English and Welsh in NZ and 3.9% in New Zealanders in
NZ). Its effect will therefore have been very slight. Bias could
occur if registry coding pracics differed between the two
countries. On enquiry, however there are no special coding
practic in either registry that could account for the results.
A large number ofcomparisons were tested for significnce
in the study, and some would be expected to be significant by
chance alone. Interpretation needs to seek connt patterns
in relation to migration, rather than simply considering indi-
vidual signnt results.
Migrants are sekcted individuals who may be atypical of
ther natie country with respect to cancer risk factors. Also,
the experience of migration may lead to atypicality with
respect to risk factors. This might explain the greater risk of
breast cancer in both of the migrant groups than in either of
the locally born populations: nulliparous women may more
easily be able to migrate than women with famili, and the
perince of migration may cause delay in garting a family.
Bearing these potential artefacts in mind, there are certain
interesting features of the data. Risks of melanoma and lip
cancer were much greater in New Zelanders in NZ than in
English and Welsh in England and Wals, as would be
expected from the greater solar ultraviolet (UV) flux
(McKenzie and Elwood, 1990) and more outdoor lifestyle in
NZ than England and Wales. The greater proportion of
Celtic-origin Britons in the population of New Zealand than
that of England and Wales may also have had a small effet,
but could not explain the scale of difference in risks. The
risks of these malignanies in migrants are of interest in
relation to the age at which aetiological factors for the
tumours act. Recent epidemiological studies of melanoma
have focused particularly on the role of childhood exposure
to UV. The raised risks of melanoma in New Zealanders in
Englad and Wales add to recent data on migants from
high- to low-risk areas of the US (Mack and Floerus, 1991)
in supporting an early exposure risk. The greater risk for
New Zealanders than for English and Welsh in NZ would
also accord with this. Mortality data for NZ have shown
greater melanoma risk (almost at native NZ klevls) for Eng-
lish and Welsh who migrated before age 30 than for those
who migrated at an oler age than this (Cooke and Fraser,
1985). It would be ofparticular interest, when sufficient years
of data have accumulated, to assess whether the relative risk
of melanoma in New Zealanders who migrate to England
and Wales after childhood diminishes with increasig years
after migration (and hence, by implication, whether diminu-
tion of sunlight exposure in adulthood can reduce risk).
For lip cancer, there were raised risks, although based on
modest numbers and not signifint, in migants in each
direcion compared with Englsh and Welsh in England and
Wales. These risks would be compatible with the gnerally
accepted relation of lip cancer aetiology to cumulative UV
exposure, such that exposures both in youth and later in life
contribute to risk.
Most eye canrs are melanomas. Unlike cutaneous
melanoma, the evidence on whether sun radiation is a major
risk factor for eye melanoma is inconclusive (IARC, 1992).
Eye cancer relative risks were raisd, but far less than for
slkin melanoma, in New Zealanders in NZ, and were similarly
raised in Englsh and Welsh migants to NZ, sugng that
the risk can be acquired by exposure to UV or some other
agent later in life. There are insufficient data to assess risks
in migrants from NZ to England and Waks.
The high risk of colon canr in NZ by international
standards has been well known for many years (Findlay et
al., 1987). The raised risk was only slightly, if at all, acquired
by English and Welsh migrants to NZ, but largely retained
by New Zealanders after migration to England and Wales,
implying that early-established habits or early exposures are
important to it. This is at variance with data on migrants
from low-risk counties to the US and Austalia, where rates
appeared to converge with host country rates in the first
generation (Haensel, 1982). Analysis of mortality and
incidence rates of colon cancr in successive birth cohorts in
New Zealand, however, has sug d the importance of
aetiological factors before 30 years of age (Cox and Little,
1992). In contrast to colon cancer, the high risks of prostatic
and thyroid caners (and, based on smaIl numbers, thymus
cancers) in NZ compared with England and Wales appeared
to be acquired by immigrants to NZ, suggsting that
exposures later in life can increase risks. For prostatic cancer,
migrants from lower risk counties to the US have also
acquired the raised risk of their host country within the first
generation (Haenszel, 1982). The prostate and thyroid, how-
ever, are both sites where there is parcular potential for
apparent canr incidence to be influenced by the extent of
diagnotic investigation, since many asymptomatic cases
occur. Thymus ancer registration rates can be affected by
decisions about the borderline between malignant and benign
thymomas, since most are morpholoclly indistingushable
(Snover et al., 1982). An alternative possible reason for dif-
ferences in rates of these tumours between England and
Wales and NZ, therefore, would be diagnostic artefact,
although this would not explain the high prostatic cancer risk
in New Zland migants to Englad and Wales.
Lung cancer risks were lower in New Zealanders in NZ
than in English and Welsh in England and Waks. This
accords with survey data on smoking habits in the two
countries, although these surveys are more recent than would
be ideal in relation to the aetiology ofthe lung canrs in the
study: in the 1981 NZ census (Department ofSta , 1983)
33% of men and 28% of women among the New Zealand-
born were current smokers compared with 47% and 36% of
adults in Britain (OPCS, 1984), and 20% and 14% of the
New Zealand-born were smnokers of 15 or more cigarettes per
day compared with 31% and 18% in Britain in 1976 (OPCS,
1978). (British data for current smokers are the average of
data for 1980 and 1982, since 1981 data are not pubished;
numbers of cigarettes smoked per day are for 1976, since
published data are not suitably subdivid thereafter, ex-
smoker data are for ex-cigarette smokers, averaging 1980 and
1982.) National data on tobacco consumption for the
decades before the dias of the ancers in this study
(Beese, 1972) are less in accord with the lang cer dif-
ferences: with the exception of the period of the Second
World War, tobacco consumption per adult was not greaterCa. i -Y Wdin NZ
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in the UK than NZ. On the other hand, manufactured
cigarette consumption was much greater in the UK than in
NZ (Beese, 1972).
The low risk oflung cancer for New Zelanders in Eng-
land and Wales would fit with the critical effect of early
smoking in establishment of the smoking habit and risk of
lung cancer (Peto, 1986). The intermediate risk for English
and Welsh in NZ may in part reflect the estaishnt of
English and Welsh smoking habits in this group at a young
age, followed by a reduction in smoking after reaching NZ.
The proportion of ex-smokers in British migrants to NZ
(33% in males, 18% in females) in the 1981 NZ census
(Department of Statistics, 1983) was greater than in either
Britain (29% and 15% respectively, OPCS, 1984) or New
Zealand non-Maoris in NZ (23% and 14%) in the same year,
while the proportions of current smokers were similar in the
British immigrants and New Zealand-born in NZ, and both
were lower than in England and Waks. The intermediate
risks may also reflect appreciable childhood migration, with
adoption of NZ smoking habits by those who migrated
young: about half of the English and Welsh in New Zealand
in 1976 had migrated in or before their early twenties
(Department of Statistics, unpublished data). Eastott (1956)
noted, more than 30 years ago, the raised risk of lung cancer
in British migrants to NZ, particularly those who migrated at
older ages, compared with NZ natives. He did not investigate
whether the migrants' risk was lower than that in Britain
Plural cancer risks were far lower in NZ than in England
and Wals, presumably because of lower levels of asbestos-
related work in NZ.
Mean alcohol consumption per capita (in 1970-72) was
appreciably greater in NZ than in the UK, and the
prevalence of hepatitis B surface antigen (HbsAg) was also
greater in NZ (Qiao et al., 1988). One might therefore expect
a greater risk of prnmary liver cancer, for which these are the
main known risk factors, in New Zealanders in NZ than in
English and Welsh in England and Wales, and this was
cleary the case in the weighted analyses at least Male but
not female migrants to NZ appear to have acquired these
raised risks, again only clarly in the weighted analysis.
Among sites related to both alohol and tobacco consum-
ption, oropharyngeal and laryngeal cancers showed no con-
sistent pattern. Oeophageal cancer risks in New Zealanders
in NZ were below those in English and Welsh in England
and Waks, and this reduction was shared by English and
Welsh migrants to NZ, whereas NZ migrants to England and
Wales of each sex had risks of oesophageal cancer 60%
above those of English and Welsh natives, albeit based on
small numbers. Haszel (1982) has noted risks of oeso-
phageal cancer above both host and native country rates in
several groups of male migrants to the US, and suggted
that this may be due to high alcohol consumption conse-
quent on the stress of migration: the risks in New Zealanders
in England and Wales, but not those in English and Welsh in
NZ, would be compatible with this.
Stomach cancer risks were much lower in NZ than Eng-
land and Wals, and significntly reduced risks compared
with those in England and Wales (although above NZ-born
levels) were present in English and Welsh migrants to NZ.
Risks in New Zealanders in England and Wales were incon-
sistent, but based on fairly small numbers. Studies of mig-
rants elsewhere have found a high risk of stomach cancer to
be retained in migrants from high- to low-risk countries
(Haenszel, 1982), suggestig a critical aetiological role for
early life exposures. Since stomach cancer is a strongly social
class-related malignancy, it is possible that if the migrants
were selece by social class their risks might reflect social
class-related behaviours, e.g. diet, before migration.
For pancreatic cancer, the low risk in New Zealanders in
NZ was shared by the rants to NZ but not by New
Zealanders in England and Wales. The approximate acquisi-
tion of host country risks by migrants would be compatible
with aetiological factors acting late in life. Pancreatic canr
risks relate to smoking, and thus the low risk in New
Zealanders in NZ accords with the lung cancer risks there.
The pancreatic cancer risks in English and Welsh in NZ also
accord to some extent with their lung cancer risk; the risks in
New Zealanders in England and Wales do not, but since they
are based on small numbers interpretation must be cautious.
Cervical cancer risks are complicated to assess since they
reflect the extent of cervcal screening and hysterectomy as
well as the effects of aetiologcal factors for the malignancy.
No data on these variables are available specifically for the
migrants. Hysterectomy rates have been higher in New Zea-
land than in Englnd and Wales (Macintosh, 1987), but this
difference and plausible differences in screening rates could
account for only a small part of the difference in risk. The
lower ovarian cancer risks in New Zealanders than English
and Welsh migrants in NZ, and in both groups than in
English and Welsh in England and Wals, fit with their
parit since ovarian cancer risk is greatest with lowest
parity. The nsk for New Zealanders in England and Wals
was not more than unity, as would be expected from their
low parity, but unlike the risks in NZ there were wide
confidence limits which included substantially raised risk.
Testcular cancer risks in NZ are among the highest in the
world (Findlay et al., 1987). The raised risks also in English
and Welsh migrants might indicate an effect of host country
behaviours or environment on risk. It might also reflect their
social class, however, if the migrants to NZ were of higher
social class, as are those from NZ to England and Wales (we
have no data on this for the migrants to NZ): testicular
cancer is substantially more common in higher social cLasses.
OveralL cancers with sizeable signifintly raised risk in
both the weighted and unweighted analyses in each sex (or in
one sex for sex-specific sites) seem the most likely to be of
aetiological interest. Such raised risks were present in New
Zealanders in NZ compared with English and Welsh in their
home country for melanoma, cancers of the lip, mouth, small
intestne, colon, thymus, prostate, eye and thyroid and non-
Hodgin's lymphoma. For each of these malignancies except
mouth, small intesftin and colon, there were also substan-
tially raised risks in English and Welsh migrants to NZ,
implying that the raised risk might be acquired by exposure
to the NZ environment or behaviours later in life. For pro-
static, thyroid and thymus cancers and non-Hodgkin's lym-
phoma, however, differences in diagnostic practices between
NZ and England and Wales are an alternative explanation
for the apparent differences in risk. For melanoma, colon
and prostatic cancers and, based on small numbers, for lip
cancer, there was raised risk in New Zealanders in England
and Waks, implying that early NZ experiences or behaviours
can alter risk. Cancers of the stomach, lung, pleura, cervix,
ovary, scrotum and penis and bladder were at sizeable and
significantly greater risk in English and Welsh in their home
country than in New Zealanders in NZ without evident
artefactual reasons for this. Of these tumours, for ancers of
the stomach, cervix and ovary the risks in migants may
reflect selective charcteristics of the migrants rather than the
effects of their exposure to the environment or behaviours of
the two counries, whereas the raised risks of lung, pleural,
scrotal and penile and bladder cancers in English and Welsh
migrants in NZ may reflect their exposures and behaviours
before migration. In future it would be of interest to inves-
tigate how the risks of cancer in migrants between NZ and
England and Wales vary with age at migration and duration
since migration, particularly for colon cancer and melanoma
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